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Background: Vogt-Koyanagi-Harada (VKH) disease is a granulomatous panuveitis, usually involving both eyes at the
same time or within a few days or weeks. Acute and chronic diseases are characterized by distinct clinical features,
treatment modalities, and visual outcomes. We report an atypical case of probable VKH disease, with features of
acute disease in one eye and chronic disease in the fellow eye.
Findings: A 53-year-old female presented with exudative retinal detachment associated with mild vitritis in the
right eye and anterior uveitis, vitritis, and sunset-glow fundus in the left eye. Based on clinical findings and results
of multimodal imaging including fundus photography, spectral-domain optical coherence tomography, fluorescein
angiography, indocyanine green angiography, and B-scan ultrasonography, a diagnosis of acute VKH disease in the
right eye and chronic VKH disease in the left eye was made. The patient received systemic corticosteroids and
mycophenolate mofetil. After a 15-month follow-up, the right fundus eye was normal, and there was a sunset-glow
fundus in the left eye.
Conclusions: VKH disease may begin with asymptomatic unilateral ocular involvement. The patient may present
only when the fellow eye is affected. A significant delay before involvement of the second eye leads to atypical
features of acute disease in one eye and chronic disease in the other eye.
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Introduction
Vogt-Koyanagi-Harada (VKH) disease is often defined as
a bilateral, chronic granulomatous panuveitis associated
with central nervous system, auditory, and integumentary
manifestations. The diagnosis is established on the basis of
the Revised Diagnostic Criteria for VKH disease [1]. The
disease is bilateral and naturally evolves through four
consecutive stages. The prodromal stage including neuro-
logical and auditory manifestations is followed after few
days by the acute uveitic stage. Acute VKH disease typic-
ally presents in the form of localized or multifocal exuda-
tive retinal detachment (ERD) associated with intraocular
inflammatory reaction. It usually affects both eyes at the
same time. However, onset may be unilateral, and the sec-
ond eye may become involved 2 to 4 weeks later [1–3].* Correspondence: moncef.khairallah@rns.tn
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the acute stage and is characterized by the development of
ocular depigmentation, the sunset-glow fundus being the
most specific feature, associated or not with integumentary
depigmentation. The chronic recurrent stage usually mani-
fests with granulomatous anterior uveitis and is associated
with higher risks of complications and vision loss [2, 3].
We report herein an atypical case of probable VKH dis-
ease with concurrent findings of acute disease in one eye
and chronic disease in the fellow eye, at first presentation.
Case report
A 53-year-old female with a history of arterial hyperten-
sion presented to our department, with bilateral vision
blurring for 5 days. She reported no previous ocular
complaints or neurological or auditory symptoms.
Best corrected visual acuity (BCVA) was 20/32 in the
right eye (RE) and 20/100 in the left eye (LE). Slit-lamp
examination showed no anterior chamber inflammationcle is distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
e appropriate credit to the original author(s) and the source, provide a link to
changes were made.
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in the anterior chamber, and localized posterior syne-
chiae in the LE. Ocular pressure was 14 mmHg in
both eyes. There were +1 vitreous cells in both eyes
and 2+ vitreous haze in the LE. Fundus examination
revealed optic disc hyperemia and a shallow ERD in
the posterior pole in the RE and diffuse depigmen-
tation producing a sunset-glow appearance with some
pigmentary changes in the LE (Fig. 1).
Spectral-domain optical coherence tomography
(SD-OCT) showed ERD with a few subretinal septa
and undulations of the retinal pigment epithelium
(RPE) in the RE. Findings were unremarkable in the
LE (Fig. 1).
Fluorescein angiography findings included multifocal
delayed choroidal perfusion, multiple areas of pinpoint
leakage, and optic disc hyperfluorescence in the RE and
areas of RPE changes that were more prominent around
the optic disc in the LE (Fig. 2). Indocyanine green angiog-
raphy revealed hypofluorescent dark dots in intermediate
and late phases in the RE and showed no obvious
abnormalities in the LE (Fig. 2). B-scan ultrasonographyFig. 1 Color fundus photography, optical coherence tomography, and ultra
presentation shows optic disc hyperemia and peripapillary exudative retina
haze and sunset-glow fundus. c, d Optical coherence tomography shows e
pigment epithelium undulations in the right eye and normal findings in th
choroidal thickening mostly around the optic disc, in the right eye, and a nshowed diffuse medium-reflective choroidal thickening
predominating around the optic nerve head in the RE and
a normal choroidal thickness in the LE. The axial length
was 23.1 mm in the RE and 23.15 mm in the LE (Fig. 1).
Medical history excluded ocular trauma or surgery.
Findings in each eye apart were very suggestive of VKH
disease, in its acute phase in the RE and in its chronic
phase in the LE. Such asymmetry being atypical, a
workup was ordered to rule out conditions mimicking
VKH disease. Results of systemic examination by the
internist, complete blood cell count, sedimentation rate,
C-reactive protein, syphilis serology, skin tuberculin test,
chest X-ray, and oculo-cerebral magnetic resonance im-
aging were unremarkable.
The patient was given oral prednisone initiated with
a dose of 1 mg/kg/day and then gradually tapered
over 6 months. In addition to that, she received
mycophenolate mofetil (2 mg a day) for a 12-month
duration. After a 15-month follow-up, the patient was
still receiving 5 mg of prednisone a day. BCVA was
20/20 in the RE and 20/25 in the LE. Right fundus
was normal (Fig. 3). There was a sunset-glow fundussonography at presentation. a Fundus photograph of the right eye at
l detachment. b Fundus photograph of the left eye shows +2 vitreous
xudative retinal detachment with a few subretinal septa and retinal
e left eye. e, f B-scan ultrasonography shows a medium-reflective
ormal choroidal thickness in the left eye
Fig. 2 Fluorescein angiography and indocyanine green angiography at presentation. a Early-phase fluorescein angiogram of the right eye
reveals multifocal areas of delayed choroidal perfusion. c Late-phase fluorescein angiogram of the right eye shows multiple areas of
pinpoint leakage and optic disc hyperfluorescence. b, d Fluorescein angiogram of the left eye shows areas of retinal pigment epithelial
changes mainly around the optic disc. e, f Intermediate-phase indocyanine green angiogram shows numerous hypofluorescent dark dots
in the right eye and no obvious abnormalities in the left eye
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peripheral nummular atrophic lesions (Fig. 4). There
were no recurrences or development of integumentary
manifestations. Ocular involvement was isolated in
our patient, and therefore, a diagnosis of probableFig. 3 Right color fundus photography at the last follow-up. Fundus
photograph of the right eye, 15 months after presentation, shows
normal findingsVKH disease was made according to the Revised
Diagnostic Criteria for VKH disease [1].
This case report was approved by the ethics committee
of Fattouma Bourguiba University Hospital, Monastir,
Tunisia.
Discussion
Our patient had an unusual presentation of VKH disease
with features of acute disease in one eye and chronic
disease in the fellow eye. Other causes of ocular inflamma-
tion including malignant hemopathies or other neoplasms,
syphilis, tuberculosis, or sarcoidosis were excluded in our
patient. The diagnosis of posterior scleritis could be ruled
out based on the lack of ocular pain and clinical and ultra-
sonographic findings.
VKH disease is usually characterized by simultaneous
onset of inflammation in both eyes, although the involve-
ment of the second eye may occur 2 to 4 weeks after the
first eye [1–3]. There have been very rare cases of VKH
disease that remained unilateral after a long follow-up
period. However, subclinical disease in the fellow eye was
not ruled out in these patients by indocyanine green angi-
ography or B-scan ultrasonography, prior to the initiation
of systemic corticosteroids [4]. Unilateral features of acute
VKH disease have also been described in a 4-year-old boy.
Fig. 4 Left color fundus photography at the last follow-up.
Composite fundus photograph of the left eye, 15 months after
presentation, shows a sunset-glow fundus with retinal pigment
epithelial changes and a few peripheral nummular atrophic lesions
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thickening in both eyes, which was consistent with bilat-
eral involvement [5]. A long delay between the first and
second eye involvement, ranging from 11 months to
6 years, has been previously reported in four patients with
a history of unilateral panuveitis before the definitive diag-
nosis of VKH disease was established. Baseline subclinical
inflammation of the initially unaffected eye might have
been overlooked in these cases [6, 7]. On the other hand,
prolonged initial unilateral ocular involvement in VKH
disease may be misdiagnosed as posterior scleritis [8].
Among these patients with a long interval before the
second eye was affected, concomitant sunset-glow fundus
in one side and ERD consistent with acute VKH disease in
the other side has been noted in only two patients [6, 7].
To the best of our knowledge, our report is the first to
describe concurrent acute VKH in one eye and sunset-
glow fundus in the fellow eye at initial presentation. This
striking contrast between the right and the left eyes
might suggest a significant delay before the second eye
was affected. However, our patient did not report any
ocular complaints when the first eye was affected. She
presented only when vision blurring became bilateral.
The mechanism of delayed involvement of the second
eye remains unclear. Early bilateral involvement with
minimal inflammation in the RE seems unlikely in
our patient. In fact, without any treatment, sunset-glow
fundus would have developed in both eyes.
In summary, patients with VKH disease may present
with atypical features of chronic disease in one eye and
acute disease in the fellow eye. Initial unilateral ocularinflammation, progressing relentlessly to chronic disease,
may remain asymptomatic until the fellow eye is involved.
Accurate diagnosis is essential for prompt initiation of
corticosteroid and immunosuppressive therapy to reduce
the risk of visual morbidity.
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